logo

Ampliphi Biosciences Corp (APHB)



Trade APHB now with
  Date
  Headline
3/25/2019 9:04:50 AM AmpliPhi Biosciences Q4 Loss Per Share $0.15 Vs Loss $0.25 Last Year
12/18/2018 6:51:38 AM AmpliPhi Biosciences Optimizes Manufacturing Process And Scale Up For AB-SA01 Clinical Development
10/17/2018 6:06:09 AM Camallergy Appoints Baxter Phillips As CEO
9/18/2018 8:12:49 AM AmpliPhi Biosciences Receives Positive Feedback From FDA Regarding Its Development Plans For AB-PA01
9/17/2018 9:03:00 AM AmpliPhi Reports Positive FDA Feedback For Clinical Stage Bacteriophage Product Candidate AB-SA01
9/17/2018 8:08:45 AM AmpliPhi Biosciences Announces Updated Positive Clinical Results For Its Expanded Access Program
8/9/2018 6:57:08 AM AmpliPhi Biosciences Q2 Loss/shr $0.19 Vs. Loss/shr $1.46 Prior Year
4/3/2018 6:52:15 AM AmpliPhi Biosciences Reports Presentation Of Bacteriophage Therapy Case Study
3/20/2018 8:05:49 AM AmpliPhi Biosciences Announces Registered Direct Offering Of 2.74 Mln Common Stockat $1.10/shr
3/13/2018 6:50:54 AM AmpliPhi To Collaborate With U.S. Department Of Veterans Affairs On Expanded Access For AB-SA01 And AB-PA01
3/9/2018 6:57:10 AM AmpliPhi Announces Presentation Of Data Showing That AB-PA01 Reduces Biofilm In Pseudomonas Aeruginosa In Vivo Model
1/10/2018 6:03:42 AM AmpliPhi Biosciences Announces Pricing Of Public Offering Of 4.0 Mln Shares At $1/Shr